Unichem Laboratories has sold balance 4918 equity shares representing 0.02% holding in Optimus Drugs to Sekhmet Pharmaventures for an aggregate consideration of Rs 67.47 crore. In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures on a fully diluted basis in the first tranche, for an aggregate consideration of Rs 270.99 crore.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1627.50 |
| Dr. Reddys Lab | 1311.00 |
| Cipla | 1289.45 |
| Zydus Lifesciences | 927.75 |
| Lupin | 2299.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: